Home / Companies / Amneal Pharmaceuticals, Inc. / 6 May 2026
Amneal Pharmaceuticals, Inc.: meeting of 6 May 2026
Votes reported on Form N-PX, item by item
417 Form N-PX filers reported votes at the Amneal Pharmaceuticals, Inc. meeting of 6 May 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
10 nominees; 71.5% of reported votes for; 96 filers withheld from or voted against at least one nominee.
3,140 vote records from 147 filers. 51 of the 146 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
647 vote records from 416 filers. 21 of the 408 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
314 vote records from 147 filers. 2 of the 146 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Amneal Pharmaceuticals, Inc. meeting?
417 Form N-PX filers reported votes at the meeting of 6 May 2026. On say-on-pay, 21 of 408 voted against management (5.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Amneal Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Amneal Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Amneal Pharmaceuticals, Inc. with a meeting date within three days of 6 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.